87 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
8 Jan 24
Regulation FD Disclosure
10:29am
Material ESG Factors Pricing & Patient Access Product Innovation Patient Safety and Product Quality Ethics & Conduct Long-Term Value Creation Culture
8-K
EX-99.2
53jci4it5861z3twou
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
04xxb6t1ly58uv8e7a
10 Oct 23
Additional proxy materials by non-management
6:48am
DEFA14A
tamdwqf6eyy3uu6j5p
26 Apr 23
Additional proxy soliciting materials
4:38pm
8-K
EX-99.1
25qcx
26 Apr 23
Bristol Myers Squibb Announces Leadership Transition Plan
4:35pm
PX14A6G
45miw0
5 Apr 22
Letter to shareholders
4:53pm
DEFA14A
s0ju9
19 Apr 21
Additional proxy soliciting materials
7:41am
PX14A6G
s1hn59el
12 Apr 21
Letter to shareholders
5:29pm